Young Beijing Scholar, Principal Investigator, Associate Chief Physician, Associate Professor, Doctoral Supervisor. Gastrointestinal Cancer Center, Peking University Cancer Hospital & Beijing Institute for Cancer Prevention and Treatment; State Key Laboratory of Integrated Prevention and Treatment of Digestive System Tumors; Frontier Science Center for Cancer Integrative Omics; Beijing Key Laboratory of Translational Research on Malignant Tumors; Peking University Institute of Advanced Clinical Medicine. Dual doctoral degrees (M.D., Ph.D.) from Peking University and Cardiff University. Primary clinical focus: Surgery-based individualized perioperative diagnosis and treatment for gastric and colorectal cancer. Research direction: Spatiotemporal evolution mechanisms and remodeling patterns of the immune microenvironment before and after perioperative comprehensive therapy. In the past five years, as corresponding/first author, published SCI papers in journals including Nature Medicine (2024, 2025), Lancet Oncology, Science Advances, Cancer Research, and Nature Review Clinical Oncology. Led 10 provincial/ministerial-level projects, including the General Program of the National Natural Science Foundation of China and the Integrated Project of the Major Research Plan of the National Natural Science Foundation of China. Has been granted 3 national invention patents and participated in the compilation of 1 monograph. Member of the International Gastric Cancer Association (IGCA); Director of the Youth Council of the China Anti-Cancer Association; Standing Committee Member of the Integrated Prevention and Screening Committee for Gastric Cancer of the China Anti-Cancer Association; Standing Committee Member of the Gastrointestinal Surgery Branch of the Beijing Integrated Medicine Association; Editorial Board Member of MedComm; Youth Editorial Board Member of Fundamental Research; Youth Editorial Board Member of Chinese Journal of Cancer Research; Youth Review Expert of the Chinese Journal of Gastrointestinal Surgery. Recipient of the First Prize of the Chinese Medical Science and Technology Award (5/15). Selected for talent programs including Young Beijing Scholar, "Young Seedling" of the Beijing Hospital Authority, the first batch of Clinical Scientists at Peking University, and Tengyun Young Scientist at Peking University. Winner of the Gold Award of the 2024 Fourth "People's Good Doctor · Jinshan Camellia Plan". Research paper recognized as one of the "Top Ten Clinical Studies in the Field of Gastrointestinal Tumors in China for 2023-2024".